Appendix 4C - Quarterly - 30 June 2022

 Balance sheet capacity with closing cash balance of $7.8M at 30 June 2022, with an additional $2M in short-term investments. Patrys Chief Executive Officer and Managing Director, Dr. James Campbell said:“Patrys has made substantial progress this quarter building out and expanding the base of evidence supporting the range of potential clinical applications for our deoxymabs. This culminated in th